← Back to Clinical Trials
Recruiting NCT07148063

NCT07148063 Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07148063
Status Recruiting
Phase
Sponsor Diskapi Yildirim Beyazit Education and Research Hospital
Condition Pediatric Anesthesia
Study Type OBSERVATIONAL
Enrollment 170 participants
Start Date 2025-09-08
Primary Completion 2026-03-13

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 8 Years
Study Type OBSERVATIONAL
Interventions
Measurement of Preoperative Inflammatory Biomarkers

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 170 participants in total. It began in 2025-09-08 with a primary completion date of 2026-03-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators. This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.

Eligibility Criteria

Inclusion Criteria: * Patients aged between 1 and 8 years * Patients with ASA physical status I-II * Patients scheduled for elective orchiopexy * Obtained written informed consent from parents/guardians Exclusion Criteria: * Patients younger than 1 year or older than 8 years * Patients with ASA physical status III or higher * Presence of acute infection signs * History of previous nausea or vomiting

Contact & Investigator

Central Contact

Elif Şule Özdemir Sezgi

✉ elifsule-91@hotmail.com

📞 00905059209638

Frequently Asked Questions

Who can join the NCT07148063 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 8 Years, studying Pediatric Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07148063 currently recruiting?

Yes, NCT07148063 is actively recruiting participants. Contact the research team at elifsule-91@hotmail.com for enrollment information.

Where is the NCT07148063 trial being conducted?

This trial is being conducted at Altındağ, Turkey (Türkiye).

Who is sponsoring the NCT07148063 clinical trial?

NCT07148063 is sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. The trial plans to enroll 170 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology